1. Home
  2. DCTH vs CYD Comparison

DCTH vs CYD Comparison

Compare DCTH & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CYD
  • Stock Information
  • Founded
  • DCTH 1988
  • CYD 1951
  • Country
  • DCTH United States
  • CYD Singapore
  • Employees
  • DCTH N/A
  • CYD N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CYD Industrial Machinery/Components
  • Sector
  • DCTH Health Care
  • CYD Industrials
  • Exchange
  • DCTH Nasdaq
  • CYD Nasdaq
  • Market Cap
  • DCTH 630.4M
  • CYD 609.7M
  • IPO Year
  • DCTH N/A
  • CYD 1994
  • Fundamental
  • Price
  • DCTH $16.21
  • CYD $17.13
  • Analyst Decision
  • DCTH Strong Buy
  • CYD
  • Analyst Count
  • DCTH 4
  • CYD 0
  • Target Price
  • DCTH $24.00
  • CYD N/A
  • AVG Volume (30 Days)
  • DCTH 610.5K
  • CYD 180.7K
  • Earning Date
  • DCTH 05-08-2025
  • CYD 02-25-2025
  • Dividend Yield
  • DCTH N/A
  • CYD 2.22%
  • EPS Growth
  • DCTH N/A
  • CYD 17.49
  • EPS
  • DCTH N/A
  • CYD 1.12
  • Revenue
  • DCTH $53,850,000.00
  • CYD $2,621,360,849.00
  • Revenue This Year
  • DCTH $141.47
  • CYD $6.43
  • Revenue Next Year
  • DCTH $49.31
  • CYD $11.20
  • P/E Ratio
  • DCTH N/A
  • CYD $15.23
  • Revenue Growth
  • DCTH 1068.87
  • CYD 6.03
  • 52 Week Low
  • DCTH $6.33
  • CYD $8.13
  • 52 Week High
  • DCTH $18.23
  • CYD $26.10
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 58.15
  • CYD 51.96
  • Support Level
  • DCTH $16.02
  • CYD $16.90
  • Resistance Level
  • DCTH $17.29
  • CYD $17.88
  • Average True Range (ATR)
  • DCTH 0.99
  • CYD 0.76
  • MACD
  • DCTH -0.03
  • CYD -0.02
  • Stochastic Oscillator
  • DCTH 49.63
  • CYD 41.44

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: